Ann Hepatobiliary Pancreat Surg.  2024 Feb;28(1):80-91. 10.14701/ahbps.23-084.

Postoperative fluid therapy in enhanced recovery after surgery for pancreaticoduodenectomy

• Koek S
• Lo J
• Ledger R
• Ballal M

• KMID: 2553369
• DOI: http://doi.org/10.14701/ahbps.23-084

Abstract

Backgrounds/Aims
Optimal intravenous fluid management during the perioperative period for patients undergoing pancreaticoduodenectomy (PD) within the framework of enhanced recovery after surgery (ERAS) is unclear. Studies have indicated that excessive total body salt and water can contribute to the development of oedema, leading to increased morbidity and extended hospital stays. This study aimed to assess the effects of an intravenous therapy regimen during postoperative day (POD) 0 to 2 in PD patients within ERAS.
Methods
A retrospective interventional cohort study was conducted, and it involved all PD patients before and after implementation of ERAS (2009–2017). In the ERAS group, a targeted maintenance fluid regimen of 20 mL/kg/day with a sodium requirement of 0.5 mmoL/kg/day was administered. Outcome measures included the mmol of sodium and chloride administered, length of stay, and morbidity (postoperative pancreatic fistula, POPF; acute kidney injury, AKI; ileus).
Results
The study included 169 patients, with a mean age of 64 ± 11.3 years. Following implementation of the intravenous fluid therapy protocol, there was a significant reduction in chloride and sodium loading. However, in the multivariable analysis, chloride administered (mmoL/kg) did not independently influence the length of stay; or rates of POPF, ileus, or AKI (p > 0.05).
Conclusions
The findings suggested that a postoperative intravenous fluid therapy regimen did not significantly impact morbidity. Notably, there was a trend towards reduced length of stay within an increasingly comorbid patient cohort. This targeted fluid regimen appears to be safe for PD patients within the ERAS program. Further prospective research is needed to explore this area.

Keyword

Fluid therapy; Pancreatic cancer; Whipple procedure; Intravenous; Acute kidney injury

Figure

• 

  Fig. 1 Total intravenous fluid administration of (A) chloride and (B) sodium. Values are expressed as mmol per kg on POD 0, 1, and 2. POD, postoperative day; ERAS, enhanced recovery after surgery.

Reference

1. Australian Institute of Health and Welfare (AIHW). 2016. AIHW statistical information system [Internet]. AIHW;Available from: https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia/contents/rankings. cited 2023 Jul 1.

2. Salem AI, Alfi M, Winslow E, Clifford SC, Weber SM. 2015; Has survival following pancreaticoduodenectomy for pancreas adenocarcinoma improved over time? J Surg Oncol. 112:643649. DOI: 10.1002/jso.24048. PMID: 26388048.

3. Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J, et al. 2006; 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg. 10:1199–1210. DOI: 10.1016/j.gassur.2006.08.018. PMID: 17114007.

4. Ljungqvist O, Scott M, Fearon KC. 2017; Enhanced recovery after surgery (ERAS): a review. JAMA Surg. 152:292–298. DOI: 10.1001/jamasurg.2016.4952. PMID: 28097305.

5. Weinberg L, Wong D, Karalapillai D, Pearce B, Tan CO, Tay S, Christophi C, et al. 2014; The impact of fluid intervention on complications and length of hospital stay after pancreaticoduodenectomy (Whipple's procedure). BMC Anesthesiol. 14:35. DOI: 10.1186/1471-2253-14-35. PMID: 24839398. PMCID: PMC4024015.

6. Lobo DN. 2009; Fluid overload and surgical outcome: another piece in the jigsaw. Ann Surg. 249:186–188. DOI: 10.1097/SLA.0b013e318197bdfc. PMID: 19212168.

7. Myles PS, Bellomo R, Corcoran T, Forbes A, Peyton P, Story D, et al. 2018; Restrictive versus liberal fluid therapy for major abdominal surgery. N Engl J Med. 378:2263–2274. DOI: 10.1056/NEJMoa1801601. PMID: 29742967.

8. Gustafsson UO, Scott MJ, Schwenk W, Demartines N, Roulin D, Francis N, et al. 2013; Guidelines for Perioperative Care in Elective Colonic Surgery: Enhanced Recovery After Surgery (ERAS^®) Society Recommendations. World J Surg. 37:259–284. DOI: 10.1007/s00268-012-1772-0. PMID: 23052794.

9. McCluskey SA, Karkouti K, Wijeysundera D, Minkovich L, Tait G, Beattie WS. 2013; Hyperchloremia after noncardiac surgery is independently associated with increased morbidity and mortality. Anesth Analg. 117:412–421. DOI: 10.1213/ANE.0b013e318293d81e. PMID: 23757473.

10. Bennett VA, Cecconi M. 2017; Perioperative fluid management: from physiology to improving clinical outcomes. Indian J Anaesth. 61:614–621. DOI: 10.4103/ija.IJA_456_17. PMID: 28890555. PMCID: PMC5579850.

11. Navarro LH, Bloomstone JA, Auler JO Jr, Cannesson M, Rocca GD, Gan TJ, et al. 2015; Perioperative fluid therapy: a statement from the international Fluid Optimization Group. Perioper Med (Lond). 4:3. DOI: 10.1186/s13741-015-0014-z. PMID: 25897397. PMCID: PMC4403901.

12. Pearse RM, Harrison DA, MacDonald N, Gillies MA, Blunt M, Ackland G, et al. 2014; Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery. JAMA. 311:2181–2190. DOI: 10.1001/jama.2014.5305. PMID: 24842135.

13. Kulemann B, Fritz M, Glatz T, Marjanovic G, Sick O, Hopt UT, et al. 2017; Complications after pancreaticoduodenectomy are associated with higher amounts of intra- and postoperative fluid therapy: a single center retrospective cohort study. Ann Med Surg (Lond). 16:23–29. DOI: 10.1016/j.amsu.2017.02.042. PMID: 28289542. PMCID: PMC5338719.

14. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. 2009; Research Electronic Data Capture (REDCap) -- a metadata driven methodology and workflow process for providing translational research informatict support. J Biomed Inform. 42:377–381. DOI: 10.1016/j.jbi.2008.08.010. PMID: 18929686. PMCID: PMC2700030.

15. Dindo D, Demartines N, Clavien PA. 2004; Classification of surgical complications. Ann Surg. 240:205–213. DOI: 10.1097/01.sla.0000133083.54934.ae. PMID: 15273542. PMCID: PMC1360123.

16. Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M, et al. 2017; The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery. 161:584–591. DOI: 10.1016/j.surg.2016.11.014. PMID: 28040257.

17. Kellum JA, Lameire N. KDIGO AKI Guideline Work Group. 2013; Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 17:204. DOI: 10.1186/cc11454. PMID: 23394211. PMCID: PMC4057151.

18. Prien T, Backhaus N, Pelster F, Pircher W, Bünte H, Lawin P. 1990; Effect of intraoperative fluid administration and colloid osmotic pressure on the formation of intestinal edema during gastrointestinal surgery. J Clin Anesth. 2:317–323. DOI: 10.1016/0952-8180(90)90077-G. PMID: 1702977.

19. Huang Y, Chua TC, Gill AJ, Samra JS. 2017; Impact of perioperative fluid administration on early outcomes after pancreatoduodenectomy: a meta-analysis. Pancreatology. 17:334–341. DOI: 10.1016/j.pan.2017.02.014. PMID: 28285959.

20. Sulzer JK, Sastry AV, Meyer LM, Cochran A, Buhrman WC, Baker EH, et al. 2018; The impact of intraoperative goal-directed fluid therapy on complications after pancreaticoduodenectomy. Ann Med Surg. 36:23–28. DOI: 10.1016/j.amsu.2018.10.018. PMID: 30370053. PMCID: PMC6199772.

21. Koek SA, Ballal MS. 2023; Impelmentation of ERAS in pancreaticoduodenectomy in an Australian tertiary centre. Pancreatology. 23:729–735. DOI: 10.1016/j.pan.2023.06.004. PMID: 37302897.

22. Thiele RH, Rea KM, Turrentine FE, Friel CM, Hassinger TE, McMurry TL, et al. 2015; Standardization of care: impact of an enhanced recovery protocol on length of stay, complications, and direct costs after colorectal surgery. J Am Coll Surg. 220:430443. DOI: 10.1016/j.jamcollsurg.2014.12.042. PMID: 25797725.

23. Miller TE, Roche AM, Mythen M. 2015; Fluid management and goal-directed therapy as an adjunct to Enhanced Recovery After Surgery (ERAS). Can J Anesth. 62:158–168. DOI: 10.1007/s12630-014-0266-y. PMID: 25391735.